These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 304375

  • 1. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM, Moccio DM, Dorick DM.
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [Abstract] [Full Text] [Related]

  • 2. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM, Donsbach RC, Moccio DM, Dorick DM.
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL, Straw JA.
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
    Chello PL, Sirotnak FM, Dorick DM, Moccio DM.
    Cancer Treat Rep; 1979 Jun; 63(11-12):1889-94. PubMed ID: 526921
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Jun; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 11. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL, Sirotnak FM.
    Cancer Treat Rep; 1981 Jun; 65(11-12):1049-53. PubMed ID: 7296551
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS.
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
    Chu BC, Howell SB.
    J Pharmacol Exp Ther; 1981 Nov; 219(2):389-93. PubMed ID: 6974776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
    Bender RA, Nichols AP, Norton L, Simon RM.
    Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.